Evarex Pharmaceuticals Private Limited, a active private limited company, was established on 18 January 2011 in Dehradun, Uttarakhand, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U51101UR2011PTC033386. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.03 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Dinesh Prasad Sati (Director), Arun Tiwari (Director), Sunita Tiwari (Director). Past directors included Namita Pandey, Girish Chandra Pandey. It holds ₹2.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No 6, Second Floor Devki Shopping Complex, Moti Bazar, Dehradun, Uttarakhand, 248001.
U51101UR2011PTC033386
033386
18 January 2011
₹5.00 M
₹2.03 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Evarex Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Prasad Sati | Director | 01 Mar 2013 | Current |
| Arun Tiwari | Director | 01 Mar 2013 | Current |
| Sunita Tiwari | Director | 18 Jan 2011 | Current |
| Sunita Juyal | Director | 01 Mar 2013 | Current |
| Vijay Kumar Juyal | Director | 18 Jan 2011 | Current |
| Namita Pandey | Director | 21 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Evarex Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.19% decrease. The company also saw a slight improvement in profitability, with a 1.3% increase in profit. The company's net worth moved up by a moderate rise of 1.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Evarex Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,225,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2020 | Canara Bank | ₹0.50 M | Open |
| 20 Jun 2020 | Canara Bank | ₹0.50 M | Open |
| 30 Dec 2017 | Canara Bank | ₹1.85 Cr | Open |
| 29 Dec 2014 | Corporation Bank | ₹1.85 M | Open |
| 24 Jul 2013 | State Bank Of India | ₹0.85 M | Open |
Explore comprehensive loan charge details -
Evarex Pharmaceuticals has a workforce of 11 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Evarex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evarex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Evarex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Evarex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 0.50 M with Charge ID 100345523 was registered on 20 Jun 2020. was documented.
A charge with Canara Bank amounted to Rs. 0.50 M with Charge ID 100345546 was registered on 20 Jun 2020. was recorded as a recent event.
The activity Namita Pandey was appointed as a Director was appointed as a Director on 21 Sep 2018 & has been associated with this company since 7 years 3 months . was completed.
A charge with Canara Bank amounted to Rs. 18.53 M with Charge ID 100173413 was registered on 30 Dec 2017. was recorded as a recent event.
The CIN of Evarex Pharmaceuticals Private Limited is U51101UR2011PTC033386.
Evarex Pharmaceuticals Private Limited is headquartered at Shop No 6, Second Floor Devki Shopping Complex, Moti Bazar, Dehradun, Uttarakhand, 248001.
Evarex Pharmaceuticals Private Limited was incorporated on 18 January 2011.
The current directors of Evarex Pharmaceuticals Private Limited are
The primary industry of Evarex Pharmaceuticals Private Limited is Pharma.
Evarex Pharmaceuticals Private Limited is unlisted.
The authorized capital of Evarex Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.03 M.
The compliance status of Evarex Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX